Cancer clinical studies

To fully protect the rights of participants in cancer clinical studies and clarify the key points for the ethics review of the content of informed consent forms and the process of collecting informed consent, the Medical Ethics Professional Committee of the China Anti-Cancer Association engaged in joint discussions with the ethics committees of well-known cancer hospitals in China to formulate this consensus, along with the attached general template for informed consent forms for cancer clinical studies. This work is expected to provide guidance and suggestions for the practice of the sponsors, researchers, and ethics committees.Cancer represents a major cause of mortality globally and by 2050 will be the major cause of ill health and death across the world, most particularly in low- and middle-income countries (LMIC). For forty years, there has been increasing recognition of the need to better understand how the modifiable factors related to diet, nutrition and physical activity can influence the risk of cancer, responses to treatment, and survival.
Cancer-related cognitive impairment (CRCI) has increasingly been identified over the last two decades in non-CNS system cancer patients. Across Europe, researchers have contributed to this effort by developing preclinical models, exploring underlying mechanisms and assessing cognitive and quality of life changes. The ultimate goal is to develop interventions to treat patients experiencing CRCI. To do so, new challenges need to be addressed requiring the implementation of multidisciplinary research groups. In this consensus paper, we summarize the state of the art in the field of CRCI combined with the future challenges and action plans in Europe. These challenges include data sharing/pooling, standardization of assessments as well as assessing additional biomarkers and neuroimaging investigations, notably through translational studies. We conclude this position paper with specific actions for Europe based on shared scientific expert opinion and stakeholders involved in the Innovative Partnership for Action Against Cancer, with a particular focus on cognitive intervention programs.
Visit for more related articles at Journal of Medical Research and Health Education
Kindly submit your article through Editorial Tracking or through medresearch@echemistry.org
With Regards
Sofia
Journal Co-ordinator
Journal of Medical Research and Health Education